Pfizer's Q2 sales fall, tofacitinib review likely delayed
July 31 2012
The company says Lipitor and other patent losses continue to plague sales and the FDA's request for new data may ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.